Verona Pharma plc·4

Feb 3, 5:58 PM ET

Deschamps Lisa 4

4 · Verona Pharma plc · Filed Feb 3, 2022

Insider Transaction Report

Form 4
Period: 2022-02-01
Transactions
  • Sale

    Ordinary Shares

    2022-02-01$0.78/sh11,664$9,06970,320 total
Footnotes (4)
  • [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
  • [F2]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units.
  • [F3]The price reported represents the sale price of the Issuer's ADSs divided by eight (8).
  • [F4]Consists of 70,320 Ordinary Shares underlying 8,790 ADSs.

Documents

1 file
  • 4
    tm225347-5_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT